Histopathological cutaneous alterations in systemic sclerosis: a clinicopathological study
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: The aims of the present study were to identify histopathological parameters which are linked to local clinical skin disease at two distinct anatomical sites in systemic sclerosis (SSc) patients with skin involvement (limited cutaneous systemic sclerosis (lcSSc) or diffuse cutaneous systemic sclerosis (dcSSc)) and to determine the sensitivity of SSc specific histological alterations, focusing on SSc patients without clinical skin involvement (limited SSc (lSSc)). METHODS: Histopathological alterations were systematically scored in skin biopsies of 53 consecutive SSc patients (dorsal forearm and upper inner arm) and 18 controls (upper inner arm). Clinical skin involvement was evaluated using the modified Rodnan skin score. In patients with lcSSc or dcSSc, associations of histopathological parameters with local clinical skin involvement were determined by generalised estimation equation modelling. RESULTS: The hyalinised collagen score, the myofibroblast score, the mean epidermal thickness, the mononuclear cellular infiltration and the frequency of focal exocytosis differed significantly between biopsies with and without local clinical skin involvement. Except for mononuclear cellular infiltration, all of the continuous parameters correlated with the local clinical skin score at the dorsal forearm. Parakeratosis, myofibroblasts and intima proliferation were present in a minority of the SSc biopsies, but not in controls. No differences were found between lSSc and controls. CONCLUSIONS: Several histopathological parameters are linked to local clinical skin disease. SSc-specific histological alterations have a low diagnostic sensitivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In skin, the presence of myofibroblasts correlates with the amount of (hyalinized) collagen and skin parameters related to fibrosis such as tightness, hardness and stiffness, and does so more significantly than inflammation (21–23), supporting for a role of myofibroblasts in the pathogenesis of these clinical signs.”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis
(2001) · Classic Papers in Rheumatology · doi:10.3109/9780203214237-95 · Cited by 3,950
Dermatology in General Medicine.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-923_2 · Cited by 3,794
Fitzpatrick’s Dermatology in General Medicine
(1999) · Heart & Lung · doi:10.1016/s0147-9563(99)70018-x · Cited by 3,233
Criteria for the classification of early systemic sclerosis.
LeRoy, E. C., & Medsger, T. A. (2001) · PubMed · Cited by 1,384
Fitzpatrick’s Dermatology in General Medicine
Dunnick, C. A. (2008) · JAMA · doi:10.1001/jama.299.10.1195-b · Cited by 1,162
Koenig, M., Joyal, F., Fritzler, M. J., Roussin, A., Abrahamowicz, M., Boire, G., Goulet, J., Rich, É., Grodzicky, T., Raymond, Y., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24038 · Cited by 615 · cited 1×
“This subset is considered to have ‘early’ SSc, as a longitudinal follow-up study has demonstrated that these patients are at risk for progression to definite SSc [ 4 ].”
BackgroundClements, P., Lachenbruch, P. A., Seibold, J. R., Zee, B. C.-Y., Steen, V. D., Brennan, P., Silman, A. J., Allegar, N. E., Varga, J., & Massa, M. C. (1993) · PubMed · Cited by 449
Sequential dermal microvascular and perivascular changes in the development of scleroderma
Prescott, R. J., Freemont, A. J., Jones, C. J. P., Hoyland, J., & Fielding, P. (1992) · The Journal of Pathology · doi:10.1002/path.1711660307 · Cited by 391 · cited 1×
“Studies of SSc skin histopathology have described alterations in different skin compartments, including atrophy and increased pigmentation of the epidermis [11], loss of the epidermal papillae [11], increase of melanophages (’pigment incontinence’) [11], the presence of a mononuclear perivascular infiltrate and myofib…”
BackgroundLymphocytes in the skin of patients with progressive systemic sclerosis
Roumm, A. D., Whiteside, T. L., Medsger, T. A., & Rodnan, G. P. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270607 · Cited by 383
Nash, R. A., McSweeney, P. A., Crofford, L. J., Abidi, M., Chen, C.-S., Godwin, J. D., Gooley, T. A., Holmberg, L., Henstorf, G., LeMaistre, C. F., et al. (2007) · Blood · doi:10.1182/blood-2007-02-072389 · Cited by 265 · cited 1×
“The histopathology of SSc skin has recently regained interest because it may be integrated as an outcome measure in clinical trials on skin disease, whereby skin biopsies are obtained before and after administration of a therapeutic drug [5,6].”
Background
Cited by
Unraveling SSc Pathophysiology; The Myofibroblast
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153
Systemic sclerosis in adults. Part I: Clinical features and pathogenesis
Jerjen, R., Nikpour, M., Krieg, T. M., Denton, C. P., & Saracino, A. (2022) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.10.065 · Cited by 160
Mathian, A., Parizot, C., Dorgham, K., Trad, S., Arnaud, L., Larsen, M., Miyara, M., Hié, M., Pietté, J. C., Francès, C., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200709 · Cited by 110
Smith, V. M., Piette, Y., Praet, J. T. V., Decuman, S., Deschepper, E., Elewaut, D. S., & Keyser, F. D. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.120778 · Cited by 103
Self-citationNikitorowicz-Buniak, J., Shiwen, X., Denton, C. P., Abraham, D., & Stratton, R. J. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.253 · Cited by 90
Chen, C., Cheng, Y., Zhu, X., Cai, Y., Xue, Y., Kong, N., Yu, Y., Xuan, D., Zheng, S., Yang, X., et al. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02285-x · Cited by 66
Lacina, L., Kolář, M., Pfeiferová, L., Gál, P., & Smetana, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1403570 · Cited by 71
Sulli, A., Ruaro, B., Smith, V., Paolino, S., Pizzorni, C., Pesce, G., & Cutolo, M. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1270-8 · Cited by 63
“lcSSc, hyalinised collagen and myofibroblasts were identified even in skin that was not clinically involved, without significant differences between lcSSc and controls [26, 27].”
BackgroundSelf-citationThe contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis
Rosa, I., Romano, E., Fioretto, B. S., & Manetti, M. (2020) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2019.19081 · Cited by 44
“Owing to their contractile force, myofibroblasts can induce substantial changes in SSc-affected skin, contributing to a progressive increase in dermal tissue stiffness, which has been recently recognized as a potent profibrotic trigger (8, 9).”
BackgroundIL-17 and related cytokines involved in systemic sclerosis: Perspectives
Gonçalves, R. S. G., Pereira, M. C., Dantas, A. T., de Almeida, A. R., Marques, C. D. L., Rêgo, M. J. B. D. M., Pitta, I. D. R., Duarte, Â. L. B. P., & Pitta, M. G. D. R. (2017) · Autoimmunity · doi:10.1080/08916934.2017.1416467 · Cited by 42
Gál, P., Brábek, J., Holub, M., Jakubek, M., Šedo, A., Lacina, L., Strnadová, K., Dubový, P., Hornychová, H., Ryška, A., et al. (2022) · Histochemistry and Cell Biology · doi:10.1007/s00418-022-02140-x · Cited by 24
The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: From Origin to Therapeutic Targeting
Romano, E., Rosa, I., Fioretto, B. S., Matucci‐Cerinic, M., & Manetti, M. (2021) · Current Molecular Medicine · doi:10.2174/0929867328666210325102749 · Cited by 26
Cutolo, M., Soldano, S., Montagna, P., Trombetta, A. C., Contini, P., Ruaro, B., Sulli, A., Scabini, S., Stratta, E., Paolino, S., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1652-6 · Cited by 27
Self-citationSchutt, C., Mirizio, E., Salgado, C. M., Reyes‐Múgica, M., Wang, X., Chen, W., Grunwaldt, L. J., Schollaert, K. L., & Torok, K. S. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41758 · Cited by 21
Ross, R. L., Caballero-Ruiz, B., Clarke, E. L., Kakkar, V., Wasson, C. W., Mulipa, P., Lorenzis, E. D., Merchant, W., Donato, S. D., Rindone, A., et al. (2024) · Rheumatology · doi:10.1093/rheumatology/keae698 · Cited by 21
Decreased CCN3 in Systemic Sclerosis Endothelial Cells Contributes to Impaired Angiogenesis
Henrot, P., Moisan, F., Laurent, P., Manicki, P., Kaulanjan‐Checkmodine, P., Jolivel, V., Rezvani, H. R., Leroy, V., Picard, F., Boulon, C., et al. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.11.026 · Cited by 22
Skin Histology in Systemic Sclerosis: a Relevant Clinical Biomarker
Showalter, K., & Gordon, J. (2020) · Current Rheumatology Reports · doi:10.1007/s11926-020-00970-z · Cited by 20
Vanhaecke, A., Cutolo, M., Heeman, L., Vilela, V. S., Deschepper, E., Melsens, K., & Smith, V. M. (2021) · Rheumatology · doi:10.1093/rheumatology/keab462 · Cited by 17
Self-citationThe role of the Notch pathway in the pathogenesis of systemic sclerosis: clinical implications
Paula, F. S., & Alves, J. D. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.2000391 · Cited by 10
“The immunological dysregulation in SSc is characterized by a mild increase of the inflammatory response both at local level (with inflammatory infiltrates in all affected organs and the persistence of an inflammatory milieu) [2] and at the”
BackgroundLenabasum for Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis
Hinchcliff, M. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41302 · Cited by 9
“The effects of lenabasum on tissuelevel phenotypes, such as hyalinized collagen score (7) or αsmooth muscle actin staining (8) as well as the recently described computer vision–generated SSc dermal Fibrosis Score (9) may provide additional key insights into the therapeutic role of CB2 stimulation in SSc dermal fibrosi…”
BackgroundZhang, G., Feng, Z., Li, C., & Huang, Z. (2025) · Journal of Biophotonics · doi:10.1002/jbio.202500299 · Cited by 8
Skin of color in dermatopathology: does color matter?
Williams, K. B., Wondimu, B., Ajayi, A., & Sokumbi, O. (2023) · Human Pathology · doi:10.1016/j.humpath.2023.04.012 · Cited by 10
Treatment of Scleroderma-Related Microstomia Using Hyaluronic Acid: An Interventional Study
Shir‐az, O., Berl, A., Mann, D., Bilal, B. S., Levy, Y. M., & Shalom, A. (2023) · Life · doi:10.3390/life13112176 · Cited by 9
“Other studies have shown variable changes, including atrophy of the epidermis, thickening of the epidermis, altered differentiation, and increased epidermal pigmentation [13–15].”
BackgroundKrishnamurthy, P., Unni, S. N., & Jayasankar, S. (2024) · Optics and Lasers in Engineering · doi:10.1016/j.optlaseng.2024.108057 · Cited by 5
Liu, T., Esencan, D., Salgado, C. M., Zhao, C., Lai, Y.-J., Hutchins, T., Sanyal, A., Chen, W., & Torok, K. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179182 · Cited by 8
“Histopathological slides from skin lesion biopsies are essential for diagnosing scleroderma due to characteristic collagen abnormalities, immune cell aggregation and architectural changes commonly observed in skin lesions of scleroderma patients [14].”
BackgroundFaber, A.-M., Krieg, T. M., & Hunzelmann, N. (2024) · Die Dermatologie · doi:10.1007/s00105-024-05298-8 · Cited by 3
“Im späteren, sklerotischen Stadium lässt sich schließlich eine verbreiterte Dermis mit einem Verlust der Reteleisten, Atrophie der Hautanhangsgebilde, verbreiterten Kolla-genfaserbündeln, verminderten und ver-schmälertenGefäßensowievermindertem Fettgewebe darstellen [43, 44].”
Gunes, I., Bernstein, E. J., Cowper, S. E., Panse, G., Pradhan, N., Camacho, L. D., Page, N., Bundschuh, E., Williams, A., Carns, M. A., et al. (2025) · Arthritis Research & Therapy · doi:10.1186/s13075-025-03508-9 · Cited by 3
Chawla, H. S., Chen, Y., Wu, M., Nikitin, P. V., Gutiérrez, J., Mohan, C., Singh, M., Aglyamov, S. R., Assassi, S., & Larin, K. V. (2025) · Journal of Biomedical Optics · doi:10.1117/1.jbo.30.3.036007 · Cited by 3
Arafat, E. A.-G., Ghoneim, F. M., & Elsamanoudy, A. Z. (2015) · The Egyptian Journal of Histology · doi:10.1097/01.ehx.0000459829.97943.23 · Cited by 3
Oganesyan, R. V., Pouli, D., Shi, B., Carns, M. A., Dennis‐Aren, K., Teves, M. E., Varga, J., & Nazarian, R. M. (2025) · Laboratory Investigation · doi:10.1016/j.labinv.2025.104177 · Cited by 2
Involvement of the Nervous System in Systemic Sclerosis
Polunosika, E., Pastare, D., Jaunozoliņa, L., & Karelis, G. (2022) · The Open Neurology Journal · doi:10.2174/1874205x-v16-2112241 · Cited by 3
Fakhouri, S. C., Zhu, H., Li, Y., Ronicke, M., Rigau, A. R., Dees, C., Konstantinidis, L., Schmid, R., Matei, A., Eckstein, M., et al. (2024) · Arthritis & Rheumatology · doi:10.1002/art.43094 · Cited by 6
“7,8 The mechanisms that are required to maintain the physiologic layered organization of healthy skin are largely unknown.”
Skin Biopsies Enhance Prediction of Clinical Trajectory in Diffuse Cutaneous Systemic Sclerosis
Lakin, K. S., Spivack, J., Gordon, J., Zhang, Y., Jannat‐Khah, D., Ravichandran, H., Anandasabapathy, N., Orange, D. E., & Spiera, R. (2025) · Arthritis & Rheumatology · doi:10.1002/art.43370 · Cited by 2
Cancer-Associated Fibroblasts and Their Role in Cancer Progression
Lacina, L., Szabó, P., Klepáček, I., Kolář, M., & Smetana, K. (2022) · Interdisciplinary cancer research · doi:10.1007/16833_2022_79 · Cited by 3
Krammer, O. B., Fleck, M., Ehrenstein, B. P., HARTUNG, W. M., & Günther, F. (2025) · Diagnostics · doi:10.3390/diagnostics15131600 · Cited by 1
Sizemore, T. C., Merchant, G., & Whitfield, K. (2015) · International Journal of Case Reports and Images · doi:10.5348/ijcri-201587-cr-10548
“parakeratosis [7, 8].”
Updates on the pathophysiology of dermal sclerosis
Yamamoto, T. (2012) · Expert Review of Dermatology · doi:10.1586/edm.12.57
Shimol, J. B., Vyas, N. S., & Evans, J. (2019) · PubMed
da Silva, D. C. Z. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2020.tde-07042021-144946
Chen, C., Cheng, Y., Zhu, X., Cai, Y., Xue, Y., Kong, N., Yu, Y., Xuan, D., 郑舒聪, Yang, X., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12864524
Pigmentary Disorders in Skin of Color
Aristizabal, M., Onajin, O., & Sokumbi, O. (2026) · Dermatologic Clinics · doi:10.1016/j.det.2026.01.013
Henrot, P. (2018) · theses.fr (ABES) · doi:10.70675/a419e36azc56fz4becz9537z0cc77ceae5ba · Cited by 1
Engineered models of skin fibrosis: from biomaterial-free to biomaterial-based in vitro systems
Amaral, S., Presa, R., & Pereira, R. F. (2026) · Biomaterials Science · doi:10.1039/d6bm00232c
Functional dermoscopy integrated by cellular-resolution Mirau-based optical coherence microscopy
Tsai, C.-C., Lee, H., Tsao, Y., Yoshizawa, A., Li, C., & Huang, S.-L. (2026) · Biomedical Optics Express · doi:10.1364/boe.606649
“For limitation, FFPE of biopsy has the risk of misdiagnosis as RBCs are still stranded in the CV without flowing [47], and capillaroscopy has no morphological structure near the obliterated CV [48].”
Vo, H., Mehendale, A. M., Azzam, M., Pilvar, A., Adili, F. E., Patel, R., Chamis, B., Ramasubramanian, A., Kissin, B., York, M., et al. (2026) · The Lancet Rheumatology · doi:10.1016/s2665-9913(26)00229-8
Metadata
- Authors
- Van Praet, J. T., Smith, V., Haspeslagh, M., Degryse, N., Elewaut, D., & De Keyser, F.
- Affiliations
- Ghent University Hospital (BE)
- Venue
- Arthritis Research & Therapy
- Published
- 2011-02
- Volume
- 13
- Issue
- 1
- Pages
- R35-R35
- ISSN
- 1478-6354 (ISSN-L)
- 1478-6362
- PMC
- PMC3241379
- OpenAlex
- W2137504948
- Cited by
- 47
- References
- 25
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 7 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 7 · 2019: 1 · 2018: 3 · 2017: 2 · 2015: 2 · 2014: 1 · 2012: 3
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- Locations
- Arthritis Research & Therapy (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
- Funders
- Vlaamse regering
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
- Keywords
- systemic sclerosis, skin involvement, limited cutaneous systemic sclerosis, diffuse cutaneous systemic sclerosis, skin histopathology, myofibroblasts, epidermal thickness, parakeratosis, intimal proliferation, modified Rodnan skin score, diagnostic sensitivity
- MeSH terms
- Adult, Biopsy, Female, Humans, Immunohistochemistry, Male, Middle Aged, Scleroderma, Systemic, Skin, Scleroderma, Limited
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.